Innodem Neurosciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2M

  • Investors
  • 3

Innodem Neurosciences General Information

Description

Developer of a mobile, artificial intelligence-powered, digital biomarker technology designed to assist in the diagnosis of neurodegenerative diseases. The company's technology is used to identify abnormalities, assess and track disease progression, monitor the effectiveness of treatment, compare it to healthy controls, and classify and assist in the diagnosis of various neurological disorders, enabling medical professionals to make informed quantitative measures for patient treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 704 Avenue de l'Épée
  • Montreal, Quebec H2V 3T9
  • Canada
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 704 Avenue de l'Épée
  • Montreal, Quebec H2V 3T9
  • Canada

Innodem Neurosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innodem Neurosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 16-Jan-2024 $2M Completed Generating Revenue
6. Later Stage VC (Series A) 01-Jul-2023 Completed Generating Revenue
5. Later Stage VC (Series A) 19-Jan-2021 Completed Generating Revenue
4. Angel (individual) Completed Generating Revenue
3. Seed Round 20-Feb-2019 Completed Generating Revenue
2. Accelerator/Incubator 16-May-2018 $78K $78K Completed Startup
1. University Spin-Out 01-Jan-2016 Completed Startup
To view Innodem Neurosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Innodem Neurosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a mobile, artificial intelligence-powered, digital biomarker technology designed to assist in the diagnosis
Diagnostic Equipment
Montreal, Canada
14 As of 2023

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Innodem Neurosciences Competitors (1)

One of Innodem Neurosciences’s competitors is Neurotrack, a Venture Capital-Backed company based in Redwood City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurotrack Venture Capital-Backed Redwood City, CA
You’re viewing 1 of 1 competitors. Get the full list »

Innodem Neurosciences Patents

Innodem Neurosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3177238-A1 A method and a system for detection of eye gaze-pattern abnormalities and related neurological diseases Active 05-May-2021
EP-4333706-A1 A method and a system for detection of eye gaze-pattern abnormalities and related neurological diseases Pending 05-May-2021
EP-4333706-A4 A method and a system for detection of eye gaze-pattern abnormalities and related neurological diseases Pending 05-May-2021
US-20250064365-A1 A method and a system for detection of eye gaze-pattern abnormalities and related neurological diseases Active 05-May-2021
WO-2022232935-A1 A method and a system for detection of eye gaze-pattern abnormalities and related neurological diseases Inactive 05-May-2021 A61B5/163
To view Innodem Neurosciences’s complete patent history, request access »

Innodem Neurosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Innodem Neurosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Morningside Group Venture Capital Minority
Centech Accelerator Accelerator/Incubator
McGill University University
To view Innodem Neurosciences’s complete investors history, request access »

Innodem Neurosciences FAQs

  • When was Innodem Neurosciences founded?

    Innodem Neurosciences was founded in 2016.

  • Where is Innodem Neurosciences headquartered?

    Innodem Neurosciences is headquartered in Montreal, Canada.

  • What is the size of Innodem Neurosciences?

    Innodem Neurosciences has 14 total employees.

  • What industry is Innodem Neurosciences in?

    Innodem Neurosciences’s primary industry is Diagnostic Equipment.

  • Is Innodem Neurosciences a private or public company?

    Innodem Neurosciences is a Private company.

  • What is Innodem Neurosciences’s current revenue?

    The current revenue for Innodem Neurosciences is .

  • How much funding has Innodem Neurosciences raised over time?

    Innodem Neurosciences has raised $11.1M.

  • Who are Innodem Neurosciences’s investors?

    Morningside Group, Centech Accelerator, and McGill University have invested in Innodem Neurosciences.

  • Who are Innodem Neurosciences’s competitors?

    Neurotrack is a competitor of Innodem Neurosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process